ORTEXORTEX News
Tracking SPNT? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SP
Earnings PreviewSPNT

SiriusPoint Reports Q2 as Peers Rally and Valuation Re-rates

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 30 Jul 2026, 03:51

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

SPNT releases Q2 earnings today with the stock up 8% over the past month and trading at its richest price-to-book multiple in 30 days — a setup that puts underwriting quality front and centre.

The valuation angle is the sharpest heading into the print. Price-to-book has expanded roughly 7% over the past month to 1.16x, and the trailing P/E has moved up in tandem to 9.6x. Both moves happened as the stock climbed from the low $24s to $25.81, meaning the re-rating is price-driven rather than estimate-driven. The EV/EBIT factor rank sits at the 91st percentile of the universe — cheap on that metric — but the EPS surprise rank of 79 suggests the company has a history of beating estimates, which is the only clean way to justify further multiple expansion from here.

The bull-bear divide is straightforward. Bulls point to the turnaround narrative: the stock has gained 17% year-to-date, the ORTEX composite score remains solid, and the low absolute P/E suggests the market is still discounting execution risk rather than pricing in a clean bill of health. Bears focus on reserve adequacy and reinsurance segment margins — concerns flagged in prior notes — and note that the CEO and CFO both sold shares in late April at $23.29, pockets below where the stock trades now. The recent analyst consensus carries a buy rating with a mean target near $26, but that data is over 100 days old and should be treated with caution; the last fresh initiations from B. Riley ($30 target, July 2025) and Oppenheimer ($25 target, June 2025) bracket the current price without offering a clear directional steer.

The peer backdrop is supportive but creates its own pressure. Closely correlated reinsurers EG, ACGL, and RNR all gained 4–6% on the week, and GLRE led the group at 7%. SPNT's 5% weekly gain kept pace but did not lead — a pattern that historically reflects investors waiting for the fundamental story to close the gap with sector momentum rather than pre-positioning aggressively.

The borrow market offers no additional signal: availability is extremely loose at roughly 1,700%, cost to borrow is negligible at 0.55%, and short interest at 3.8% of free float has barely moved. Options positioning is call-heavy with a put/call ratio of 0.025, only modestly above its 20-day average and well below any historical stress reading. Today's print is therefore a test of whether SiriusPoint's underwriting margins and reserve development can justify the multiple that a strong sector tape has handed it.

Stocks in this article

See the live data behind this article on ORTEX.

Open SPNT on ORTEX →

How this article was generated

Generated
30 Jul 2026, 04:25
Data as of
30 Jul 2026, 03:51
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.